Ten years of non-occupational HIV post-exposure prophylaxis: what have we learned?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ten years of non-occupational HIV post-exposure prophylaxis: what have we learned? ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1, 12.2008
- Creator
-
Tissot, F.
- Contributor
-
Fardel, V.
Cavassini, M.
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-11-S1-P231
- URN
-
urn:nbn:de:1111-2016052056891
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tissot, F.
- Fardel, V.
- Cavassini, M.
- SpringerLink (Online service)
Other Objects (12)
Development of the non-occupational post-exposure prophylaxis (NPEP) knowledge scale among Chinese men who have sex with men
Service outcome of antiretroviral Post-Exposure Prophylaxis (PEP) for occupational HIV exposure among health care personnel
Pre-Exposure Prophylaxis (PrEP)
High risk for occupational exposure to HIV and utilization of post-exposure prophylaxis in a teaching hospital in Pune, India
GOAL: What Have We Learned?
Post-exposure prophylaxis during pandemic outbreaks
Examining potential effects of non-occupational post-exposure prophylaxis (nPEP) on sexual behaviors of Chinese men who have sex with men: a cross-sectional study
Radiation exposure and occupational risks
Parsonage-Turner syndrome following post-exposure prophylaxis
Zika Virus: What Have We Learned?
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01
Best practices for identifying men who have sex with men for corrections-based pre-exposure prophylaxis provision
Development of the non-occupational post-exposure prophylaxis (NPEP) knowledge scale among Chinese men who have sex with men
Service outcome of antiretroviral Post-Exposure Prophylaxis (PEP) for occupational HIV exposure among health care personnel
Pre-Exposure Prophylaxis (PrEP)
High risk for occupational exposure to HIV and utilization of post-exposure prophylaxis in a teaching hospital in Pune, India
GOAL: What Have We Learned?
Post-exposure prophylaxis during pandemic outbreaks
Examining potential effects of non-occupational post-exposure prophylaxis (nPEP) on sexual behaviors of Chinese men who have sex with men: a cross-sectional study
Radiation exposure and occupational risks
Parsonage-Turner syndrome following post-exposure prophylaxis
Zika Virus: What Have We Learned?
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01
Best practices for identifying men who have sex with men for corrections-based pre-exposure prophylaxis provision
Development of the non-occupational post-exposure prophylaxis (NPEP) knowledge scale among Chinese men who have sex with men
Service outcome of antiretroviral Post-Exposure Prophylaxis (PEP) for occupational HIV exposure among health care personnel
Pre-Exposure Prophylaxis (PrEP)
High risk for occupational exposure to HIV and utilization of post-exposure prophylaxis in a teaching hospital in Pune, India
GOAL: What Have We Learned?
Post-exposure prophylaxis during pandemic outbreaks
Examining potential effects of non-occupational post-exposure prophylaxis (nPEP) on sexual behaviors of Chinese men who have sex with men: a cross-sectional study
Radiation exposure and occupational risks
Parsonage-Turner syndrome following post-exposure prophylaxis
Zika Virus: What Have We Learned?
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01